Journal article
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG
MS Binkley, JL Brady, C Hajj, M Chelius, K Chau, A Balogh, M Levis, AR Filippi, M Jones, S Ahmed, M MacManus, A Wirth, M Oguchi, AK Vistisen, TY Andraos, AK Ng, BMP Aleman, SH Choi, YM Kirova, S Hardy Show all
International Journal of Radiation Oncology Biology Physics | ELSEVIER SCIENCE INC | Published : 2019
Abstract
Purpose: We previously reported that ∼30% of patients with localized follicular lymphoma (FL)staged by 18F-fluorodeoxyglucose positron emission tomography-computed tomography receiving primary radiation therapy (RT)will relapse within 5 years. We sought to report outcomes for those who relapsed. Methods and Materials: We conducted a multicenter, retrospective study of patients aged ≥18 years who received RT ≥ 24 Gy for stage I to II, grade 1 to 3A FL, staged with 18F-fluorodeoxyglucose (18F-FDG)positron emission tomography-computed tomography. Observation was defined as >6 months without treatment from relapse. Overall survival (OS)and freedom from progression (FFP)were estimated with Kaplan..
View full abstractGrants
Awarded by NCI NIH HHS